Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Coronary Artery Disease|May 1, 1994
Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgeryW M Halbmayer, A Haushofer, J Radek, et al.Coronary Artery Disease|May 1, 1995
Platelet size, fibrinogen and lipoprotein(a) in coronary heart diseaseW M Halbmayer, A Haushofer, J Radek, et al.Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Prediction of recurrent venous thromboembolism by the activated partial thromboplastin timeG Hron, S Eichinger, A Weltermann, et al.Thrombosis and Haemostasis|January 1, 1994
The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donorsW M Halbmayer, A Haushofer, R Schön, et al.Zeitschrift Fur Kardiologie|January 1, 1995
[Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent]M Dittel, A Haushofer, R Spiel, et al.Thrombosis and Haemostasis|February 12, 1991
C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsiaW M Halbmayer, P Hopmeier, C Mannhalter, et al.Wiener Klinische Wochenschrift|July 13, 1990
[A simple test for the monitoring of plasma anti-XA activity of patients following subcutaneous administration of enoxaparin]W M Halbmayer, C Feichtinger, T Schwarz, et al.Deutsche Medizinische Wochenschrift (1946)|October 29, 1993
[Recurrent venous thromboses in hypoplasia of the vena cava inferior and factor XII deficiency]W M Halbmayer, J Radek, P Duschet, et al.The Clinical Investigator|July 1, 1994
High-dose intravenous melphalan in a patient with multiple myeloma and oliguric renal failureM Pecherstorfer, I Zimmer-Roth, S Weidinger, et al.British Journal of Haematology|December 31, 1997
A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiencyS Mustafa, I Pabinger, K Vàradi, et al.Pageof 4